NSE - Delayed Quote INR

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

1,590.20

+5.40

+(0.34%)

At close: June 6 at 3:30:01 PM GMT+5:30

Glenmark Pharmaceuticals Ltd (BOM:532296) Q4 2025 Earnings Call Highlights: Strong FY25 Revenue ...

Glenmark Pharmaceuticals Ltd (BOM:532296) reports a robust 12.8% revenue growth for FY25, driven by European expansion and consumer care success, despite North American setbacks.

GuruFocus.com 12 days ago

GLENMARK.NS
+0.34%
Glenmark Pharmaceuticals Ltd (BOM:532296) Q3 2025 Earnings Call Highlights: Robust Revenue ...

Glenmark Pharmaceuticals Ltd (BOM:532296) reports a 35.1% revenue surge in Q3 FY25, driven by strong performance in India and strategic global expansions.

GuruFocus.com 3 months ago

GLENMARK.NS
+0.34%

Performance Overview

Return	GLENMARK.NS	S&P BSE SENSEX (^BSESN)
YTD	-1.17%	+5.18%
1-Year	+31.63%	+9.48%
3-Year	+309.49%	+47.62%